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Summary
Background: A number of adhesion-mediated signaling path-
ways and cell-cycle events have been identified that regulate
cell proliferation, yet studies to date have been unable to
determine which of these pathways control mitogenesis in
response to physiologically relevant changes in tissue elas-
ticity. In this report, we use hydrogel-based substrata matched
to biological tissue stiffness to investigate the effects of matrix
elasticity on the cell cycle.
Results: We find that physiological tissue stiffness acts as
a cell-cycle inhibitor in mammary epithelial cells and vascular
smooth muscle cells; subcellular analysis in these cells, mouse
embryonic fibroblasts, and osteoblasts shows that cell-cycle
control by matrix stiffness is widely conserved. Remarkably,
most mitogenic events previously documented as extracel-
lular matrix (ECM)/integrin-dependent proceed normally
when matrix stiffness is altered in the range that controls mito-
genesis. These include ERK activity, immediate-early gene
expression, and cdk inhibitor expression. In contrast, FAK-
dependent Rac activation, Rac-dependent cyclin D1 gene
induction, and cyclin D1-dependent Rb phosphorylation are
strongly inhibited at physiological tissue stiffness and rescued
when the matrix is stiffened in vitro. Importantly, the combined
use of atomic force microscopy and fluorescence imaging in
mice shows that comparable increases in tissue stiffness
occur at sites of cell proliferation in vivo.
Conclusions: Matrix remodeling associated with pathogen-
esis is in itself a positive regulator of the cell cycle through
a highly selective effect on integrin-dependent signaling to
FAK, Rac, and cyclin D1.
Introduction
Soluble mitogens and antimitogens have long been viewed as
important regulators of cell proliferation, but it is now accepted
that insoluble factors, especially components of the extracel-
lular matrix (ECM), have equally essential roles in the prolifer-
ation of most nontransformed cell types. Soluble mitogens
and ECM proteins jointly regulate activation of the G1 phase
cyclin-dependent kinases (cdks) cdk4/6 and cdk2, which are
required for S phase entry [1]. ECM proteins signal by binding
and activating the integrin family of cell surface receptors, and
many studies have identified integrin-dependent signaling
events that support G1 phase progression, especially the
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3These authors contributed equally to this workinduction of cyclin D1 mRNA and protein and the downregula-
tion of the cip/kip family of cdk inhibitors [1]. These effects
control activation of cdk4/6 and cdk2, respectively, which in
turn catalyze the inactivating phosphorylations of the retino-
blastoma protein (Rb) and the related proteins p107 and
p130. Rb phosphorylation results in the release of sequestered
E2Fs and the induction of E2F-dependent genes required for S
phase.
Integrin-dependent signaling events implicated upstream
of cyclin D1 and the cip/kips include the activation of ERK
MAP kinases, Rho family GTPases, and FAK [1]. However,
little is known about whether and how these pathways are
activated in physiologically relevant mechanical microenvi-
ronments. This gap in knowledge arises at least in part
because integrin-regulated events have typically been identi-
fied in cultured cells after complete blockade of ECM-integrin
binding (e.g., by incubating cells in suspension or on polyly-
sine-coated dishes) or by preventing integrin clustering
(e.g., by disrupting the actin cytoskeleton with depolymerizing
drugs or inhibitors of Rho GTPase activation or signaling).
These approaches result in much more severe changes in in-
tegrin occupancy, F-actin polymerization, and Rho GTPase
activity than are likely to occur physiologically. Additionally,
a pervasive shortcoming of traditional cell biological ap-
proaches to the study of ECM function is that cells are typi-
cally cultured on nondeformable substrata (culture dishes or
glass coverslips), which have little relationship to the elastic
(also called ‘‘compliant’’) ECM that cells encounter in vivo.
Because a hallmark of ECM-cell interactions is the ability to
sense extracellular stiffness, tissue compliance may be an
important determinant of downstream adhesion-dependent
signaling events.
Some studies have used collagen gels to study the effect of
a more compliant matrix on integrin signaling and the cell
cycle. These studies showed that human foreskin fibroblasts
in free-floating collagen gels have high levels of p27, do not
phosphorylate ERK, and do not express cyclin D1 [2, 3]. Others
have reported that increased p21cip1 or p15INK4B is responsible
for G1 phase arrest that occurs when cells are plated on soft
collagen gels [4, 5]. FAK autophosphorylation, ERK activity,
and Rho activation are also impaired when cells are cultured
on or in soft collagen matrices or Matrigels [2, 6]. Although
these results suggest that changes in matrix stiffness recapit-
ulate the effects seen upon complete adhesion blockade,
collagen gels are much softer than many physiological tissues
(elastic moduli of 10–50 pascals [Pa] versus 100–100,000 Pa)
[7, 8]. Moreover, changing the stiffness of collagen gels by
altering collagen concentration inherently affects the integrin
ligand concentration, so observed effects cannot be strictly
attributed to changes in matrix elasticity. The same complica-
tion exists when cells are cultured in Matrigel, which is also
less well defined chemically.
Careful control of substratum elasticity is perhaps best
achieved by seeding cells on ECM-coated biocompatible hy-
drogels because elasticity can be varied independently of
matrix concentration [9, 10]. Hydrogels based on polyacryl-
amide have elastic moduli of w1,500–150,000 Pa, a range
which encompasses the stiffness of most physiological
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Figure 1. Selective Effect of Extracellular Matrix Stiffness on Cyclin D1 Gene Expression
(A) Serum-starved cells were stimulated with mitogens, incubated with bromodeoxyuridine (BrdU), and reseeded on hydrogels made with a constant 7.5%
acrylamide. Bis-acrylamide varied from 0.03% to 0.3%. After 24 hr (MCF10A cells and mouse embryonic fibroblasts [MEFs]) or 48 hr (vascular smooth
muscle cells [VSMCs]), cells were fixed and BrdU incorporation was determined. The graph compiles results from an individual experiment for each cell
type and shows percent maximal BrdU incorporation compared to the stiffest hydrogel. The shaded area highlights the range of elastic moduli measured
in mouse mammary glands and arteries as determined by milliprobe indentation and atomic force microscopy (AFM) (see Table S2).
(B) MEFs were synchronized at G0 (by 48 hr serum starvation) or at G2/M (by treatment with 5 mg/ml nocodazole for 24 hr). The cells were reseeded on hydro-
gels and stimulated with 10% fetal bovine serum (FBS). RNA was isolated 24 hr after reseeding and analyzed by qPCR for cyclin A or cyclin D1 mRNAs. Data
in (B) and (C) are mean 6 standard deviation (SD) of duplicate PCR reactions.
(C) Serum-starved cells were reseeded on high-stiffness (H) and low-stiffness (L) hydrogels with mitogens. Cyclin D1 mRNA was measured by qPCR at times
corresponding to optimal induction (12 hr for MCF10A cells, 24 hr for VSMCs, and 9 hr for MEFs).
(D and E) Serum-starved MEFs were pretreated with dimethyl sulfoxide (vehicle) or U0126 (U0) prior to reseeding on hydrogels and stimulation with 10%
FBS. Reseeded cells were collected at the indicated times and analyzed by western blotting.tissues [10]. Cells plated on soft hydrogels show a decrease in
cell number [9, 11], but the molecular events that underlie cell-
cycle control by matrix stiffness remain undefined. In this
report, we combine biophysical measurements of tissue elas-
ticity with a molecular analysis of the cell cycle on compliance-
appropriate hydrogels to elucidate the subcellular effects of
matrix stiffness on cell proliferation.
Results
A Small Subset of Adhesion-Dependent Signaling Events
Accounts for Cell-Cycle Control by Matrix Stiffness
We adapted the use of deformable matrix protein-coated
acrylamide hydrogels to a molecular analysis of the cell cycle.
Quiescent mouse embryonic fibroblasts (MEFs) were plated
on fibronectin (FN)-coated hydrogels having elastic moduli
within the physiological range [7, 12]. Serum-stimulated cell-cycle entry was barely detected when MEFs were seeded on
low-stiffness FN substrata (elastic modulus < 2000 Pa), and
the degree of S phase entry increased with matrix stiffness
until optimal cycling was obtained atw24,000 Pa (Figure 1A).
Remarkably, the same range of matrix stiffness regulated S
phase entry in MCF10A mammary epithelial cells (Figure 1A),
vascular smooth muscle cells (VSMCs; Figure 1A), and osteo-
blastic cells (see Figure S1 available online). Thus, the effect of
matrix stiffness on G1 and S phase progression is widely
conserved and independent of the rigidity of individual tissue
microenvironments. Mitogenesis (assessed as mRNA induc-
tion of cyclin A, an E2F target required for S phase entry and
progression) was dependent on matrix stiffness regardless
of whether cells entered G1 phase from G0 or G2/M
(Figure 1B), indicating that both cell-cycle reentry from quies-
cence and subsequent cycling are controlled by ECM stiff-
ness. Subsequent experiments used hydrogels prepared at
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stiffness, respectively.
As in previous reports [13, 14], cell spreading and cytoskel-
etal organization were inhibited when either epithelial or mes-
enchymal cells were plated on the low-stiffness acrylamide
hydrogels (Figure S2). Because decreased cell spreading has
been associated with decreased integrin signaling and S
phase entry [15], we initially thought that the cell-cycle inhibi-
tion reflected an overall decrease in integrin signaling. Overall
inhibition of integrin signaling prevents the mitogen-depen-
dent induction of cyclin D1 mRNA and the mitogen-dependent
downregulation of the p21cip1 and p27kip1 cdk inhibitors [1, 16,
17]. In contrast, the soft substratum that prevents mitogenesis
inhibited the induction of cyclin D1 mRNA and protein (Figures
1C and 1D) but not the G1 phase downregulation of p21cip1 or
p27kip1 (Figure 1E). Thus, matrix compliance targets a discrete
subset of adhesion-dependent cell-cycle events. Cyclin D1
gene expression was similarly regulated by matrix stiffness
in cells entering G1 phase from G0 or G2/M (Figure 1B).
Previous studies on glass or plastic substrata have indi-
cated that the mid-G1 phase induction of cyclin D1 requires
sustained ERK activity [18, 19]. In agreement with these
results, we found that serum-stimulated MEFs plated on the
high-stiffness substratum used ERK activity to induce cyclin
D1 protein as determined with the MEK inhibitor U0126
(Figure 1D). However, a comparison of ERK activation in cells
cultured on low- and high-stiffness substrata showed that the
magnitude and duration of ERK phosphorylation were not
strongly affected by this range of ECM stiffness (Figure 2A;
Figure S3A) despite large differences in expression of cyclin
D1 (Figures 1C and 1D) and mitogenesis (Figure 1A). Induction
of the ERK-dependent immediate-early genes Fra-1 and JunB,
associated with cyclin D1 gene expression [18, 19], was also
similar on the high- and low-stiffness substrata (Figures 2B–
2D; Figure S3B), indicating that ERK translocation to the
nucleus and ERK-dependent transcription were proceeding
normally. Thus, despite the fact that ERK activity is adhesion
dependent as determined by the complete blockade of cell
adhesion or actin depolymerization [1], changes in ERK
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Figure 2. Regulation of Mitogenesis and Cyclin D1 Gene Expression
by Extracellular Matrix Stiffness Is ERK Independent
(A) Serum-starved MEFs were reseeded on hydrogels and stimu-
lated with 10% FBS. Reseeded cells were collected at the indicated
times and analyzed by western blotting.
(B–D) Serum-starved cells were reseeded on high-stiffness (H) and
low-stiffness (L) hydrogels with mitogens. RNA was collected from
quiescent cells (G0) and cells stimulated with 10% FBS at times
optimal for JunB and Fra-1 mRNA induction (1 and 3 hr, respectively)
in the three cell types. Fra-1 and JunB mRNA levels were determined
by qPCR and normalized to 18S rRNA and are plotted relative to the
levels of the high-stiffness samples. Data are mean 6 SD of dupli-
cate PCR reactions.
activity are not responsible for the effect of matrix stiff-
ness on cyclin D1 gene expression.
Regulated FAK Localization as a Mechanosensor
for Cell-Cycle Progression
The overall extent of immediate-early gene induction,
cyclin D1 gene induction, and mitogenesis was similar
in cells plated on glass versus the high-stiffness hydro-
gels (Figure S4), but focal adhesions were less robust
than those seen on traditional glass coverslips as
assessed by immunostaining for FAK, Y397-phosphorylated
FAK (FAKpY397), vinculin, and paxillin (Figure S5). By these
same criteria, focal adhesions were undetected in cells plated
at low matrix stiffness (Figure S5). FAK phosphorylation has
been linked to mechanotransduction and cyclin D1 gene
expression [20–22], and indeed we found that FAK autophos-
phorylation at Y397 was reduced when cells were cultured on
the low-stiffness ECM (Figure 3A). Conversely, ectopically
expressed FRNK or nonphosphorylatable FAK (FAKY397F) sup-
pressed cyclin D1 mRNA expression in MEFs incubated on the
high-stiffness ECM (Figures 3B and 3C). This effect did not
reflect a global disruption of integrin complexes, because vin-
culin-containing focal adhesions persisted in the presence of
FRNK or FAKY397F (Figure S6). Cyclin D1 induction was also
impaired in FAK null cells (Figure S7A). Thus, FAK inhibition
or depletion on stiff substrata phenocopies the effect of low
matrix stiffness on cyclin D1 gene expression.
However, we saw variable degrees of inhibition of Y397
phosphorylation (w30%–80%) when serum-stimulated cells
were plated on low-stiffness hydrogels despite consistent
inhibitory effects on cyclin D1 mRNA. Additionally, an acti-
vated FAK allele, CD2-FAK [23], failed to rescue cyclin D1
gene expression (Figure 3D) in MEFs plated on soft FN-coated
hydrogels despite efficient ectopic expression (see Figure 3D
legend) and localization to focal adhesions on the high-
stiffness substratum (Figure S8). Thus, constitutive FAK
activity is not sufficient to overcome the inhibitory effect of
the low-stiffness matrix on S phase entry. We therefore
considered the possibility that matrix compliance was regu-
lating the association of FAK with integrins. Indeed, confocal
immunofluorescence microscopy showed that endogenous
FAK and activated integrins (assessed by talin staining; [24])
efficiently colocalized in MEFs cultured on the high-stiffness
ECM but not in MEFs cultured on the low-stiffness ECM
(Figure 3E; Figures S9A and S9B). These results extend work
of others showing that matrix stiffness controls formation of
b1-integrin/FAK/talin complexes as determined by coimmuno-
precipitation in ectopic expression paradigms [20]. They also
distinguish the integrin complexes that form in response to
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adhesions, and 3D adhesions (which are reported to have
constitutive recruitment of FAK to integrins) and reveal
a potential similarity to fibrillar adhesions [25]. A compliance-
dependent regulation of FAK localization can explain why
expression of CD2-FAK does not rescue cyclin D1 gene induc-
tion on a low-stiffness substratum whereas mislocalization of
endogenous FAK with FRNK or FAKY397F inhibits cyclin D1
gene expression on a stiff substratum. Collectively, these
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Figure 3. FAK Is Linked to Stiffness-Dependent Induction of Cyclin D1
mRNA
(A) Serum-starved cells were reseeded on high-stiffness (H) and low-stiff-
ness (L) hydrogels with mitogens, collected 3 hr after reseeding, and
analyzed by western blotting. The vertical white line in the MCF10A blot indi-
cates where extraneous information was removed from the blot.
(B) Starved MEFs infected with adenoviruses encoding LacZ (control, 2) or
GFP-FRNK (+) were reseeded on hydrogels with 10% FBS. Cyclin D1 mRNA
was measured by qPCR.
(C) The experiment in (B) was repeated with an adenovirus encoding
FAKY397F (at 250, 500, and 1500 moi) rather than FRNK.
(D) Starved MEFs infected with adenoviruses encoding LacZ or CD2-FAK
(50 and 100 moi) were incubated on hydrogels with 10% FBS, and cyclin
D1 mRNA was measured by qPCR. CD2-FAK percent infection was
70%–90% as determined from its GFP internal ribosome entry site. Data
in (B)–(D) are mean 6 SD of duplicate PCR reactions.
(E) Asynchronous MEFs were reseeded on hydrogels. Cells were fixed 24 hr
after reseeding and immunostained for FAK and talin. FAK and talin coloc-
alization was determined as described in Experimental Procedures and in
the Figure S9 legend. Results are plotted as mean colocalization 6 SD
(p < 1026).results indicate that cells respond to changes in extracellular
stiffness by regulating the degree to which FAK is stably asso-
ciated with activated integrins. In this model, compliance-
dependent changes in FAK autophosphorylation are a
secondary consequence of altered FAK-integrin association.
Mechanical Signaling to the Cell Cycle Transduced
by the FAK-Rac-Cyclin D1 Pathway
Studies on glass or plastic substrata have indicated that
FAK can regulate at least four effectors of cyclin D1 gene
expression: ERK activity [26], Rho activity [27], expression of
the transcription factor KLF8 [22], and Rac activity [28, 29].
We investigated which, if any, of these effector pathways
was responsible for the induction of cyclin D1 by matrix stiff-
ness. We could discount ERK as the critical FAK effector
because ERK activity was not strongly inhibited by functionally
relevant changes in matrix stiffness (Figure 2) or FRNK
(Figure S7B). Rho activity is inhibited by the low-stiffness
substrata ([6]; Figure S10A), but we reasoned that Rho is not
the major FAK effector, at least in terms of ECM compliance,
because Rho has been linked to cyclin D1 gene expression
through ERK and because expression of activated Rho did
not rescue cell spreading (Figure S10B) or cyclin D1 gene
expression in serum-stimulated MEFs cultured on a soft
substratum in either the absence or presence of activated
FAK (Figure S10C). Expression of KLF8 mRNA was barely
detectable by quantitative real-time reverse transcriptase-
polymerase chain reaction (qPCR) in MEFs (w100-fold lower
levels than transcripts for Fra-1 or JunB; Table S1), as ex-
pected from work by others demonstrating that FAK overex-
pression is required for KLF8 induction [22].
We recently reported that the mid-G1 phase induction of
cyclin D1 mRNA requires Rac activity [30], and indeed we found
that Rac inhibition blocked mitogen-stimulated cyclin D1
mRNA induction when cells were plated on the high-stiffness
substratum (Figure 4A). Moreover, Rac GTP loading in MEFs
(Figures 4B and 4C) and VSMCs (Figure S11) was strongly in-
hibited by the low-stiffness substratum, whereas expression
of an activated Rac (RacV12) rescued cyclin D1 gene expression
on the soft substratum (Figure 4D). The effect of matrix stiffness
on Rac-dependent cyclin D1 gene expression requires FAK,
because FRNK or FAKY397F expression blocked Rac activity
on the high-stiffness matrix (Figures 4B and 4C). Collectively,
these data causally link FAK-dependent Rac activation to the
effect of ECM compliance on cyclin D1 expression. However,
activated Rac did not rescue S phase entry in MEFs on the
soft substratum (Figure 4E), indicating that there must be an
additional effect of matrix elasticity on mitogenesis.
Matrix Stiffness Regulates Cyclin D1-Dependent
Rb Phosphorylation
The mid/late-G1 phase phosphorylation of Rb results in the
release of associated E2Fs and transcription of E2F-depen-
dent genes required for S phase entry. Rb phosphorylation,
as determined by gel shift, and induction of cyclin A were in-
hibited by low matrix stiffness in MEFs (Figure 5A). Ectopically
expressed cyclin D1 rescued Rb phosphorylation, but efficient
rescue required high levels of overexpression (Figure 5B; >100
moi). More moderate overexpression (30 moi) rescued Rb
phosphorylation poorly despite readily detected cdk4
(Figure 5B). Similarly, cyclin D1 overexpression rescued S
phase entry (determined as Ki-67-expressing nuclei) poorly
in serum-stimulated MEFs on the low-stiffness ECM, even
though inactivation of Rb with HPV-E7 rescued mitogenesis
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Figure 4. Matrix Stiffness Regulates the FAK-
Rac-Cyclin D1 Signaling Pathway
(A–D) Serum-starved MEFs were infected with
adenoviruses encoding GFP (control), RacN17,
RacV12, FRNK, or FAKY397F. Cells were reseeded
on high-stiffness (H) and low-stiffness (L) hydro-
gels and stimulated with 10% FBS for 9 hr to
measure induction of cyclin D1 mRNA by qPCR
(A and D) or for 30 min to measure Rac GTP
loading by G-LISA (B and C). Data in (A) are
mean 6 SD of duplicate PCR reactions. For (B)
and (C), each cell lysate was incubated in dupli-
cate wells coated with Rac-GTP binding protein;
data are mean6 SD of the duplicates. Data in (D)
are mean and standard error of the mean of three
experiments. Statistical significance was deter-
mined by t test (*p = 0.029; **p = 0.015; #p =
0.19, not significant).
(E) The experiment in (D) was repeated, except
that the cells were incubated with BrdU and fixed
at 24 hr for determination of S phase entry.efficiently (Figure 5C). Similar results were observed with
MCF10A cells (Figure S12). Inefficient Rb phosphorylation
could result from upregulated expression of inhibitory proteins
for cdk4/6 (the INK4s) or cdk2 (the cip/kips) because these
cdks jointly inactivate Rb. However, none of the INK4s (p15,
p16, p18, and p19; Figure 5D) or the widely expressed cip/
kips (p21 and p27; see Figure 1E) were regulated by the range
of matrix stiffness that controls mitogenesis. Collectively,
these data indicate that ECM compliance regulates cyclin
D1-dependent Rb phosphorylation most likely through an
effect on cdk4/6 binding and/or activity. The integrin signaling
mechanism underlying the effect of matrix stiffness on cyclin
D1-dependent Rb phosphorylation requires FAK, because
ectopically expressed FRNK inhibited S phase entry in
serum-stimulated cyclin D1-overexpressing MEFs cultured
on high-stiffness hydrogels (Figure 5E). Conversely, CD2-
FAK synergized with ectopically expressed cyclin D1 to
promote S phase entry in cells on the low-stiffness substratum
(Figure 5F), reaching about half of the level of bromodeoxyur-
idine (BrdU) incorporation seen on the high-stiffness ECM.
Tissue Stiffening at Sites of Cell Proliferation In Vivo
To test the link between tissue stiffness and cell proliferation
in vivo, we first isolated mammary glands, thoracic aortae,
and femoral arteries from mice and compared their elasticities
to the range of matrix stiffness that regulates mitogenesis as
determined by the hydrogel analyses. Milliprobe indentation
or atomic force microscopy (AFM) indicated that these tissues
have an elastic modulus range of 600–4300 Pa (Table S2). This
stiffness range strongly inhibits mitogenesis (see Figure 1A),
indicating that physiological compliance of the mammary
gland and major arteries acts as a cell-cycle inhibitor.
We then used fine-wire femoral artery injury in mice to
examine potential changes in tissue stiffness occurring at sites
of cell proliferation in vivo. The injury procedure disrupts the
integrity of the intimal endothelium, allowing for platelet aggre-
gation and the dedifferentiation of medial VSMCs to a prolifer-
ative state. Although an intact endothelium is eventually
restored, the transient denudation results in the formation ofa ‘‘neointima’’ containing proliferating VSMCs. Immunohisto-
chemistry confirmed VSMC proliferation, as assessed by
BrdU incorporation, in the neointima of injured arteries (Fig-
ure 6A). These regions of cell proliferation could be localized
by monitoring a-smooth muscle actin (SMA) expression, which
is lost in both the neointima and underlying media as VSMCs
dedifferentiate to the proliferative state (Figure 6A, box 3 in
right panel). Note, however, that the SMA staining pattern of
the artery was mosaic and that positive staining regions
were also detected. These SMA-positive regions likely reflect
uninjured areas of the artery (see box 1) and sites of injury
where VSMCs have dedifferentiated, proliferated, and then
redifferentiated (boxes 2 and 4).
We rendered the vascular injury model compatible with the
analysis of stiffness in fresh tissue by performing femoral
artery injuries on transgenic mice in which the SMA promoter
drives GFP. Vascular injury in this line resulted in discrete
GFP-positive and -negative regions (Figure 6B), whereas
GFP fluorescence in uninjured control arteries was nearly
uniform (Figure 6B). We used AFM in force mode to probe
the compliance of the GFP-negative regions (neointimas) and
compared the results to those obtained for the uninjured
contralateral arteries of the same SMA-GFP mice. We ex-
cluded GFP-positive regions of injured arteries from the anal-
ysis in order to eliminate the confounding effects of VSMC
redifferentiation (see above). The results revealed regions of
clear arterial stiffening 2 weeks after injury (the time at which
BrdU incorporation is detected in vivo), with an increase in
both the mean stiffness and variance at sites of VSMC prolifer-
ation (Figure 6C). Remarkably, the degree of stiffening seen at
sites of injury and VSMC proliferation in mice reached the
range of elastic moduli that supported mitogenesis in the
hydrogel studies (Figure 1A).
Discussion
Matrix Stiffness and the Cell Cycle
Our study describes cellular and molecular effects of matrix
compliance on the cell cycle. The elastic moduli that regulate
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Figure 5. Matrix Stiffness Regulates Cyclin D1 Function Downstream of Its Expression
(A) Starved MEFs were reseeded on hydrogels with 10% FBS. Cell lysates were collected and analyzed by western blotting.
(B) Starved MEFs infected with adenoviruses encoding LacZ or cyclin D1 (30–300 moi) were reseeded on hydrogels with 10% FBS. Cells were collected at
24 hr and analyzed by western blotting.
(C) Starved MEFs infected with adenoviruses encoding GFP (1000 moi), cyclin D1 (100, 300, and 1000 moi), or HPV-E7 (100, 300, and 1000 moi) were
reseeded on high-stiffness (H) and low-stiffness (L) hydrogels and incubated with 10% FBS. S phase entry was measured 24 hr after plating by immunos-
taining for Ki-67.
(D) Starved MEFs were reseeded on hydrogels with 10% FBS. INK4 mRNA levels were measured by qPCR. Data are mean6 SD of duplicate PCR reactions.
(E) Starved MEFs infected with adenoviruses encoding cyclin D1 (100 moi) and either LacZ or GFP-FRNK were reseeded in 10% FBS with BrdU. Cells were
fixed at 24 hr for analysis of BrdU incorporation.
(F) MEFs infected with adenoviruses encoding GFP, CD2-FAK, cyclin D1 (100 moi), or cyclin D1 and CD2-FAK were starved and plated on high- and low-
stiffness substrata and stimulated with 10% FBS for 24 hr; S phase entry was determined by BrdU incorporation.mitogenesis in MEFs, mammary epithelial cells, VSMCs, and
osteoblastic cells are strikingly similar, indicating that the
effect of tissue compliance on the cell cycle is widely con-
served and independent of a cell’s particular microenviron-
ment. The mitogen-dependent induction of cyclin D1 mRNA
is strongly affected by the range of matrix elasticity that
controls mitogenesis, whereas other mitogenic events previ-
ously identified as being integrin dependent (the expression
of cdk-inhibitory proteins and immediate-early genes, as well
as the activation of ERK) are relatively resistant. Thus, adhe-
sion-mediated cell-cycle events in G1 phase are not binary
but have distinct compliance thresholds, with many of the
previously identified events proceeding normally in the range
of matrix stiffness that strongly inhibits mitogenesis.
In addition to regulating the expression of cyclin D1, matrix
stiffness controls the ability of ectopically expressed cyclin
D1 to stimulate Rb phosphorylation and S phase entry. This
effect is of particular interest in mammary cells given the
frequent overexpression of cyclin D1 in breast cancer [31,
32]. A common idea is that overexpressed cyclin D1 acts coop-
eratively with other oncogenic events, and our results indicate
that tissue stiffening, a hallmark of mammary tumors, can beconsidered as one of these complementing oncogenic events
because it is required for the efficient function of overex-
pressed cyclin D1. Additionally, our data indicate that onco-
genic events inactivating Rb, such as expression of HPV-E7,
can override the inhibitory effect of physiological ECM compli-
ance on the cell cycle without increasing ECM stiffness
because they deregulate the molecular events targeted by
tissue compliance.
FAK Localization as a Mechanosensor for the Cell Cycle
Paszek et al. [6] reported that FAK phosphorylation at Y397,
but not its localization to integrins, is regulated by matrix stiff-
ness in mammary epithelial cells and fibroblasts. Although we
also observed changes in FAK autophosphorylation in re-
sponse to changing extracellular stiffness and intracellular
tension, our data and those of Wei et al. [20] support a model
in which FAK localization, rather than its autophosphorylation
at Y397, represents the primary compliance effect. Wozniak
et al. [33] also described a compliance-dependent localization
of FAK in mammary cells undergoing tubulogenesis.
Although CD2-FAK is unable to rescue cyclin D1 expression
in cells plated on a low-stiffness substrate, CD2-FAK is able to
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a large part of S phase entry. These results suggest that the
inhibitory effects of low matrix stiffness on cyclin D1 mRNA
and cyclin D1-dependent mitogenesis are mechanistically
distinct downstream of FAK. We envision that differential
localization of the relevant FAK substrates will ultimately
Figure 6. In Vivo Arterial Stiffening at Sites of Cell Proliferation
Six-month-old male C57BL/6 mice were subjected to fine-wire femoral
artery injury and administered BrdU.
(A) The external and internal elastic laminae (EEL and IEL, respectively) were
visualized by elastin staining, and overall arterial morphology was deter-
mined by staining with hematoxylin and eosin. These procedures allowed
for the identification of the adventitia (AD), the medial layer of VSMCs (M),
and the site of injury (NI, neointima). Adjacent sections were analyzed by
immunohistochemistry with anti-BrdU (1299964, Roche) to visualize prolif-
erating cells (left panel) and anti-a-smooth muscle actin (clone 1A4, Sigma)
to visualize regions of differentiated and dedifferentiated VSMCs (right
panel). Clockwise and counterclockwise arrows in the right panel indicate
the IEL and EEL, respectively. Boxed regions highlight distinct patterns of
VSMC differentiation in the media and neointima.
(B) Six-month-old male SMA-GFP mice were subjected to fine-wire femoral
artery injury. Uninjured and contralateral injured arteries were isolated, care-
fully opened, and imaged for GFP fluorescence. Representative areas of
uninjured and injured arteries are shown for a single mouse.
(C) Uninjured (control) and injured femoral arteries from SMA-GFP mice
were collected 2 weeks after the fine-wire injury procedure. AFM was
used to measure the elastic modulus of several GFP-positive regions of
uninjured arteries and GFP-negative regions of injured arteries. The figure
compiles AFM measurements obtained from four mice (p = 0.0029 by
one-way t test with Welch correction for unequal variance; p for unequal
variance < 0.0001).account for these differential effects of CD2-FAK on compli-
ance-dependent cell cycling. The focal adhesion proteins
paxillin and p130Cas have the potential to regulate the FAK-
dependent activation of Rac through CrkII-DOCK180/Elmo or
Pkl-Pix-Pak, and both proteins have been implicated in
mechanosensing [34, 35]. It will be interesting to determine
whether FAK and these focal adhesion components have
common or distinct compliance thresholds for localization to
activated integrins. Because activated Rac does not rescue
S phase entry in cells plated on the low-stiffness substratum,
the FAK effector pathway (or pathways) regulating cyclin
D1-dependent Rb phosphorylation extends beyond Rac.
Tissue Stiffness and Cell Cycling In Vivo
Direct measurement of arterial elasticity at sites of proliferation
in mice demonstrates that tissue stiffness increases at sites of
VSMC proliferation in vivo and that regions of the remodeled
matrix attain elastic moduli compatible with cell cycling.
Although the relationship between arterial compliance and
VSMC proliferation in vivo is complicated by pulsatile blood
flow, the plasticity of VSMC differentiation, and the effects of
antiproliferative signals derived from adjacent intimal endo-
thelial cells [36], our studies indicate that injury-associated
change in the elasticity of the VSMC microenvironment is a crit-
ical regulator of proliferation in cardiovascular disease. Al-
though we studied tissue stiffness at sites of vascular injury,
a comparable elastic modulus has been reported for athero-
sclerotic lesions [37]. Similarly, the reported elastic moduli of
mammary tumors [38] should be sufficient to support cyclin
D1 gene induction and mitogenesis according to our hydrogel
analysis. Thus, control of the cell cycle by tissue compliance
may contribute widely to the absence of cell proliferation in
normal tissues as well as to the increased proliferation of cells
seen during pathological ECM remodeling and stiffening of the
microenvironment.
Experimental Procedures
Serum-starved cells were trypsinized and replated on matrix protein-coated
acrylamide hydrogels [39] and stimulated with mitogens. Cells were lysed
and analyzed for expression of mRNA and protein by qPCR and western
blotting, respectively. Rac and Rho GTPase activity were determined by
G-LISA (Cytoskeleton). Epifluorescence microscopy was used to measure
BrdU incorporation and Ki-67 and to visualize F-actin [39]. Focal adhesion
formation was determined by confocal immunofluorescence microscopy,
and FAK-talin colocalization was quantified by morphometric analysis of
confocal images. The elastic moduli of mouse mammary glands, aortae,
and femoral arteries were determined with a custom-made microindenter
or by AFM in force mode. Some experiments used cells infected with adeno-
viruses encoding LacZ, GFP, cyclin D1, HPV-E7, or dominant-negative or
activated alleles of FAK and Rac. See Supplemental Experimental Proce-
dures for detailed materials and methods.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, three
tables, and twelve figures and can be found with this article online at http://
www.cell.com/current-biology/supplemental/S0960-9822(09)01548-6.
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